About company

Website currently under construction HOX Therapeutics is an early-stage cancer research company, spun off from the University of Surrey Oncology Department. We are focused on the potential to treat cancer based on two independent programmes which involve the inhibition of HOX genes and androgen receptors. While the inhibition of HOX genes may have broad anti-cancer…

GB
Unknown
Not verified company